Filtered By:
Vaccination: Hepatitis Vaccine

This page shows you your search results in order of date. This is page number 19.

Order by Relevance | Date

Total 557 results found since Jan 2013.

Abstracts of Presentations at the Association of Clinical Scientists 143 < sup > rd < /sup > Meeting Louisville, KY May 11-14,2022
Conclusion: These assays are suitable for routine diagnostic. The UltraFast NextGenPCR is the fastest with average time (30mins), followed by Agilent (2 hrs) and MassArray (6hrs). Upon completion of this activity, participants should be able to examine, measure and compare results from different assays for SARS detection, evaluate and diagnose accurately, as well as being able to plan, organize and recommend a diagnostic procedure for diagnostic laboratory. Key words: SARS-CoV-2, RNA extraction, RT-PCR, limit of detection, quantification cycle, COVID-19, in vitro diagnostic tests, Agilent, Massarray, Ultrafast. [20] From t...
Source: Annals of Clinical and Laboratory Science - July 1, 2022 Category: Laboratory Medicine Source Type: research

South Korea Approves First Domestically Developed COVID-19 Vaccine
SEOUL, South Korea — Health officials in South Korea on Wednesday approved the country’s first domestically developed COVID-19 vaccine for people 18 years or older, adding another public health tool in the fight against a prolonged pandemic. In clinical trials involving some 4,000 participants in South Korea and five other countries, SK Bioscience’s two-dose SKYCovione vaccine appeared to be more effective than the broadly used AstraZeneca shots in building immunity against infections, officials at South Korea’s Food and Drug Safety Ministry said. It isn’t immediately clear how officials will ...
Source: TIME: Health - June 29, 2022 Category: Consumer Health News Authors: Kim Tong-hyung / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news

A Fourth COVID-19 Vaccine, From Novovax, Passed a Key Stage in the Authorization Process
American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot. Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. It’s made with more conventional technology than today’s dominant Pfizer and Moderna shots and the lesser-used Johnson & Johnson option. Novavax shots are already available in Australia, Canada, parts of Europe and multiple other countries, either for initial va...
Source: TIME: Health - June 8, 2022 Category: Consumer Health News Authors: LAURAN NEERGAARD / AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news

FDA Advisers Back a New COVID-19 Vaccine, Made By Novavax
American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot. Next, the FDA must decide whether to authorize the vaccine made by latecomer Novavax, a protein vaccine that’s made with a more conventional technology than today’s U.S. options. Novavax shots are already used in Australia, Canada, parts of Europe and dozens of other countries. But U.S. clearance is a key hurdle for the Maryland-based company. FDA’s vaccine chief Dr. Peter Marks said another choice in the U....
Source: TIME: Health - June 7, 2022 Category: Consumer Health News Authors: Lauran Neergaard / AP Tags: Uncategorized COVID-19 wire Source Type: news

FDA advisers recommend authorizing Novavax coronavirus vaccine
The Novavax vaccine is a protein vaccine, a more traditional technology found in other commonly used immunizations such as hepatitis B and influenza.
Source: Washington Post: To Your Health - June 7, 2022 Category: Consumer Health News Authors: Carolyn Y. Johnson Source Type: news

Case Report: Acute Posterior Multifocal Placoid Pigment Epitheliopathy after SARS-CoV-2 Vaccination
CONCLUSIONS Acute posterior multifocal placoid pigment epitheliopathy is a self-limited inflammatory condition of the outer retina that usually affects young adults and often does not require treatment. It has been reported to occur after vaccination for influenza, polio, hepatitis B, meningococcus C, and varicella zoster virus. This is the first known case to occur after SARS-CoV-2 vaccination in a healthy adolescent boy.
Source: Optometry and Vision Science - June 1, 2022 Category: Opthalmology Tags: REPORTS Source Type: research

CDC Backs Travel Testing; Pediatric Hepatitis Probe Expands; Shkreli Leaves Prison
(MedPage Today) -- Note that some links may require registration or subscription. CDC now advises the public to take a coronavirus test before domestic travel, vaccinated or not. (Washington Post) In response to the baby formula shortage, President...
Source: MedPage Today Gastroenterology - May 19, 2022 Category: Gastroenterology Source Type: news

Exacerbation of Familial Intrahepatic Cholestasis in Conjunction with COVID-19 Vaccination
The highly transmissible Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) leading to coronavirus disease 2019 (COVID-19) is imposing a devastating global impact, leading to the fast development of efficient anti-COVID-19 vaccines. These may rarely impose side effects including autoimmune hepatitis 1,2.
Source: Journal of Hepatology - May 15, 2022 Category: Gastroenterology Authors: Yakir Guri, J ürg Vosbeck, Michael Dickenmann, Alexander Jetter, Christine Bernsmeier Tags: Letter to the Editor Source Type: research

Reduction of ACE2 serum concentrations by telbivudine in chronic hepatitis B patients
CONCLUSION: Telbivudine treatment reduced sACE2 concentrations, which could potentially reduce the infection risk of SARS-CoV-2.PMID:35538813 | DOI:10.2174/1566524022666220510220533
Source: Molecular Medicine - May 11, 2022 Category: Molecular Biology Authors: Ya-Hui Huang Chau-Ting Yeh Chao-Wei Hsu Yang-Hsiang Lin Source Type: research